company background image
OBI logo

Ondine Biomedical AIM:OBI Stock Report

Last Price

UK£0.087

Market Cap

UK£24.3m

7D

-2.8%

1Y

-22.2%

Updated

05 Nov, 2024

Data

Company Financials +

Ondine Biomedical Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ondine Biomedical
Historical stock prices
Current Share PriceUK£0.087
52 Week HighUK£0.12
52 Week LowUK£0.05
Beta0.10
11 Month Change37.25%
3 Month Change11.11%
1 Year Change-22.22%
33 Year Changen/a
5 Year Changen/a
Change since IPO-84.91%

Recent News & Updates

Recent updates

Is Ondine Biomedical (LON:OBI) In A Good Position To Invest In Growth?

Sep 28
Is Ondine Biomedical (LON:OBI) In A Good Position To Invest In Growth?

Shareholder Returns

OBIGB Medical EquipmentGB Market
7D-2.8%-8.3%-1.2%
1Y-22.2%-1.7%8.9%

Return vs Industry: OBI underperformed the UK Medical Equipment industry which returned -1.7% over the past year.

Return vs Market: OBI underperformed the UK Market which returned 8.9% over the past year.

Price Volatility

Is OBI's price volatile compared to industry and market?
OBI volatility
OBI Average Weekly Movement10.1%
Medical Equipment Industry Average Movement5.6%
Market Average Movement4.7%
10% most volatile stocks in GB Market9.6%
10% least volatile stocks in GB Market2.6%

Stable Share Price: OBI's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: OBI's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
1996n/aCarolyn Crossondinebio.com

Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its product platform is Photodisinfection, a light-based antimicrobial technology that provides destruction of pathogens without causing antibiotic resistance. The company’s lead product is Steriwave, a nasal photodisinfection solutions that destroys bacteria, viruses, and fungi colonizing the nose which leads to healthcare-associated infections.

Ondine Biomedical Inc. Fundamentals Summary

How do Ondine Biomedical's earnings and revenue compare to its market cap?
OBI fundamental statistics
Market capUK£24.26m
Earnings (TTM)-UK£7.92m
Revenue (TTM)UK£906.45k

26.8x

P/S Ratio

-3.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OBI income statement (TTM)
RevenueCA$1.63m
Cost of RevenueCA$653.00k
Gross ProfitCA$981.00k
Other ExpensesCA$15.26m
Earnings-CA$14.27m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.051
Gross Margin60.04%
Net Profit Margin-873.56%
Debt/Equity Ratio0%

How did OBI perform over the long term?

See historical performance and comparison